News Column

OTC Markets Group Congratulates Cellectar Biosciences on NASDAQ Listing

August 30, 2014



By a News Reporter-Staff News Editor at Investment Weekly News -- OTC Markets Group Inc. (OTCQX: OTCM) congratulates Cellectar Biosciences Inc., on its successful public offering and approval to list on The NASDAQ Capital Market, effective August 15, 2014. Cellectar previously traded on OTCQX, the best marketplace for established U.S. and global companies operated by OTC Markets Group.

Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO

Cellectar, a biopharmaceutical company, joined OTCQX on February 16, 2012. Since that time, Cellectar's 30-day daily average dollar volume has increased 248%, reflecting increased investor interest in its securities.

"We congratulate Cellectar on achieving this major milestone," said R. Cromwell Coulson, President and CEO of OTC Markets Group. "Cellectar's success on OTCQX demonstrates its strength of execution and ability to leverage OTCQX as an efficient and informed public market. We wish the company continued success as they take this next step."

OTCQX is the marketplace of choice for U.S. and global companies that are looking to execute their business plans and graduate to a U.S. stock exchange listing. Cellectar is the fifth company to move from OTCQX to the NYSE MKT or NASDAQ markets this year. Others include: BioPath Holdings Inc., Gulf Coast Ultra Deep Loyalty Trust, RXI Pharmaceuticals Corp. and Sphere 3D Corp.

Keywords for this news article include: OTC Markets Group Inc, Investment and Finance.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Investment Weekly News


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters